QingSong Health and Basel Medical Partner for AI Healthcare Expansion in SE Asia

Key Facts

1QingSong Health signed a strategic cooperation memorandum with Basel Medical Group to explore AI-enabled healthcare services in Southeast Asia.

Amid the accelerating digital transformation of medical services in emerging markets, QingSong Health Corp has announced a strategic memorandum of understanding with Basel Medical Group. This partnership aims to explore and develop AI-enabled healthcare services across Southeast Asia. According to reports, the cooperation will focus on integrating medical solutions with insurance services and facilitating cross-border healthcare delivery.

This move comes as the region experiences significant growth in the health-tech sector, with Hong Kong-listed Chinese firms like 2661.HK seeking geographical revenue diversification. Compared to peers, major sector players such as Ping An Healthcare (1833.HK) recorded a 14.2% growth in active users over the past year per Bloomberg data, bolstering positive outlooks for QingSong's regional expansion plans.

Operationally, investors should monitor the transition of this non-binding MOU into definitive agreements as a primary catalyst for the stock. Looking at economic data, Chinese exports grew by 19.4% (as of June 9, 2026), indicating a favorable environment for outbound expansion. The market also awaits partnership updates alongside the company's upcoming periodic earnings announcements.